Division of Nuclear Chemistry & Technology

ltbluln.gif (484 bytes)

215th ACS National Meeting March 29 - April 2, 1998, Dallas, Texas

SUNDAY MORNING

Honoring Ray Sheline, Recipient of the 1998 ACS Award for Nuclear Chemistry
Sponsored by Gordon and Breach Publishers

Session 1           N. Johnson, Presiding,  M. A. Riley, Organizer

9:00 Introductory Remarks
9:05 1. Award address for the ACS Award in Nuclear Chemistry, sponsored by Gordon and Breach: The structure of matter implied by the hierarchy of spectroscopies. R. K. Sheline
9:40 2. Molecular analogies in nuclear spectroscopy. J. O. Rasmussen
10:15 Intermission
10:35 3. New studies on the dynamical and chemical properties of nanoparticles. M. A. El-Sayed
11:10 4. Radionuclides in the environment. G. R. Choppin
11:45 5. Developments in fission, fusion, clusterradioactivity and the extension of the periodic system of elements. W. Greiner

SUNDAY AFTERNOON

Section A

Honoring Ray Sheline, Recipient of the 1998 ACS Award for Nuclear Chemistry
Sponsored by Gordon and Breach Publishers

Session 2           G. Strubble, Presiding

1:45 6. Experiments with fast radioactive beams. P. G. Hansen
2:20 7. Nuclear shell effects as a function of deformation, particle number and angular momentum. I. Ragnarsson
2:55 8. Sheline and his West Coast allies explore nuclear structure with tritium-induced reactions at LANL's ion beam facility. J. A. Becker
3:30 Intermission
3:45 9. Octupole collectivity in atomic nuclei. P. D. Cottle
4:20 10. Experiments on simple excitations of nuclei close to 208Pb. K. H. Maier
4:55 11. Octupole Excitations in 208Pb and adjacent nuclei. S. W. Yates, M. Yeh, M. Kadi, P. E. Garrett, C. A. McGrath, T. Belgya

Section B

Therapeutic Radionuclides: Making the Right Choice

Session 1           S. C. Srivastava, Organizer, Presiding, C. J. Anderson, Organizer

1:30 Introductory Remarks
1:40 12. Production of therapeutic radioisotopes at the University of Missouri Research Reactor. A. R. Ketring, G. J. Ehrhardt, D. Ma, M. S. Evans-Blumer
2:05 13. Accelerator production of high specific activity therapeutic radionuclides. T. J. Ruth
2:30 14. Development of electron emitting radionuclides for therapy at BNL. L. F. Mausner, K. F. Kolsky, S. C. Srivastava
2:50 15. Production of radionuclides for therapy using small cyclotrons. M. J. Welch, D. W. McCarthy, J. B. Downer, M. R. Lewis, R. E. Shefer, R. E. Klinkowstein, B. J. Hughey
3:15 Intermission
3:30 16. Rethinking radionuclide therapy. R. W. Atcher
3:50 17. Comparison of alpha-emitting radionuclides for cancer treatment. D. R. Fisher
4:10 18. Auger electron emitters for intracellular therapy. S. B. Mirzadeh, F. F. Knapp, Jr.
4:30 19. Oak Ridge National Laboratory alpha emitter program - production of thorium-229 from uranium-233. O. F. Webb, A. M. Krichinsky, S. B. Mirzadeh, B. D. Patton
4:50 20. Rhenium-188 - an attractive readily available generator-produced radioisotope for intravascular inhibition of coronary restenosis and cancer therapy. S. B. Mirzadeh, F. F. Knapp, Jr., A. L. Beets
5:10 21. Production of 86Y via the 86Sr(p,n) reaction for positron emission tomography. S. C. Shoner, K. A. Krohn, J. F. Eary

Section C

Additional Aspects of Nuclear Science

A. C. Mignerey, Organizer, Presiding, L. R. Morss, Organizer, Presiding

1:30 22. Whole column radioactivity detection:simultaneous liquid chromatographic separation and enhanced detectability. J. M. Link, R. E. Synovec
1:50 23. Magnetic resonance sensing system for on-line monitoring of 99Tc in radioactive tank waste cleanup processes. S. L. Dieckman, J. H. Meiser, L. G. Waterfield, S. E. Slaughter, J. A. Jendrzejczyk, A. C. Raptis
2:10 24. Quantitative analysis of gallium in plutonium using laser induced breakdown spectroscopy. C. A. Smith, M. A. Martinez, D. K. Veirs
2:30 25. Containment of molten plutonium using levitation. M. S. Blau
2:50 26. New macromolecular hosts for pertechnetate sensing and remediation. J. A. Gawenis, S. S. Jurisson, K. T. Holman, J. L. Atwood
3:10 27. Stability of lanthanide and actinide complexes of a hexadentate nitrogen donor. L. R. Morss, M. P. Jensen, D. D. Ensor
3:30 28. Nitrogen-13 production from porous poly(styrene/divinylbenzene) for use in positron emission tomography. E. M. Zippi, M. Hoffmeyer, C. Brewster
3:50 29. The isotope record of diffusive fractionation of magnesium and noble gases in the solar wind and in solar flares. D. E. Ragland, O. K. Manuel
4:10 30. Nuclear stimulated processes at metal oxide/water interfaces and their relevance to degradation of spent nuclear fuel. P. E. Haustein
4:30 31. K-East Basin canister sludge gas generation. P. R. Bredt, D. L. Rinehart
4:50 32. Design of calixarene derived bifunctional chelating reagents for a-emitter Ac-225. X. Chen, M. Ji, D. R. Fisher, C. M. Wai
5:10 33. The isotope record of local element syntheses and formation of the solar system. O. K. Manuel

MONDAY MORNING

Section A

Therapeutic Radionuclides: Making the Right Choice

Session 2           C. J. Anderson, Organizer, Presiding

8:30 34. The present and future role of radionuclide unsealed source therapy. A. J. McEwan, L. I. Wiebe
8:55 35. Radionuclides for treatment of bone pain from metastatic malicnancy. H. L. Atkins, S. C. Srivastava
9:20 36. Influence of nuclear and chemical properties on the efficacy and safety of samarium Sm-153 lexidronam. W. F. Goeckeler
9:45 37. Tin-117m (4+) chelates for treatment of metastatic bone pain. S. C. Srivastava, H. L. Atkins, G. E. Meinken, L. F. Mausner
10:10 38. Radiation synovectomy with samarium-153 hydroxylapatite. J. W. Brodack
10:35 Intermission
10:45 39. Standardization of radionuclides used in bone palliation therapy. B. E. Zimmerman, B. M. Coursey, J. T. Cessna
11:05 40. Standards and measurements for radionuclides used in intravascular brachytherapy. B. M. Coursey, R. Colle, B. E. Zimmerman, L. R. Karam, M. P. Unterweger, D. B. Golas
11:25 41. Rhenium-188 labeled a-melanotropin analogs as potential radiotherapeutic agents. S. S. Jurisson, T. Quinn, N. Wang, M. Giblin, J. Chen
11:50 42. Yttrium-90 microshere therapy for liver tumors. R. H. Reid
12:10 43. Genetic radioisotope targeting strategies for cancer therapy. B. E. Rogers, D. T. Curiel, D. J. Buchsbaum

Section B

Nuclear Structure with Large Gamma-Ray Detector Arrays and their Auxiliary Devices

Session 1           D. G. Sarantities, Organizer, S. L. Tabor, Presiding

8:30 Introductory Remarks
8:35 44. Superdeformation at the south-west shore of the mass 190 island. W. Reviol, L. L. Riedinger, B. H. Smith, M. P. Carpenter, S. M. Fischer, R. V. F. Janssens, T. L. Khoo, T. Lauritsen, D. T. Nisius, E. F. Moore, P. Fallon
9:10 45. In-beam spectroscopy at the limit: Studies of very neutron-deficient radon isotopes. S. J. Freeman, R. B. Taylor, R. Julin, M. Leino
9:45 46. Studying excited states in nuclei beyond the proton drip-line. M. P. Carpenter, H. Amro, D. J. Blumenthal, L. T. Brown, C. N. Davids, S. M. Fischer, R. V. F. Janssens, T. L. Khoo, T. Lauritsen, C. J. Lister, D. T. Nisius, D. Seweryniak
10:20 Intermission
10:30 47. Proton emitters - spherical and deformed. C. N. Davids, P. J. Woods, D. Seweryniak, A. Sonzogni, J. C. Batchelder, C. R. Bingham, T. Davinson, D. J. Henderson, R. J. Irvine, G. L. Poli, J. Uusitalo, W. B. Walters
11:10 48. What's up at Genie: Studies of proton rich nuclei, double phonon excitations, actinide cross sections. J. A. Becker
11:45 49. Fission-fragment gamma spectrometry with large arrays. A. G. Smith, J. Billowes, J. L. Durell, W. R. Phillips, G. Simpson, S. J. Freeman, M. Leddy, A. Jungclaus, C. Teich, N. Schulz, B. J. P. Gall, F. Hoellinger, I. Ahmad

Section C

Thirty Years of Research in Nuclear Dynamics: from Fission to the Quark-Gluon Plasma - in Memory of Kevin L. Wolf

Session 1           R. Schmitt, Organizer, Presiding, J. O. Rasmussen, Presiding

9:00 Introductory Remarks
9:05 50. Sideways peaking in multifragmentation: shock waves, toroids or kinemaitcs? V. E. Viola
9:50 51. Non-equilibrium phenomena in nuclear reactions at Fermi energies. W. U. Schroeder
10:30 Intermission
10:50 52. Nuclear multifragmentation and critical phenomena. R. P. Scharenberg
11:30 53. Directed and elliptic flow in 158 GeV/A Pb + Pb collisions. A. M. Poskanzer

MONDAY AFTERNOON

Section A

Therapeutic Radionuclides: Making the Right Choice

Session 3           S. S. Jurisson, Presiding

1:30 54. Reagents for the delivery of therapeutic metals to tumor sites. C. F. Meares
1:55 55. The role of kidney uptake in the choice of a therapeutic radionuclide. W. C. Eckelman, L. Lang, E. Jagoda, C. Wu, M. W. Brechbiel, O. A. Gansow, I. Pastan, C. H. Paik, J. A. Carrasquillo
2:20 56. Copper-64-labeled monoclonal antibodies for radioimmunotherapy (RIT). C. J. Anderson, J. M. Connett, T. Buettner, S. W. Schwarz
2:45 57. Formylation of functionalized P-H bonds: A novel approach to the design of synthons for use as ligands in nuclear medicine. K. V. Katti, S. R. Karra, R. Schibli, H. Gali, A. R. Ketring, W. A. Volkert
3:10 58. Improved internalizing I-131-monoclonal antibodies for therapy. S. V. Govindan, D. M. Goldenberg, R. Stein, M. J. Mattes, L. B. Shih, W. J. McBride, H. J. Hansen, G. L. Griffiths
3:30 Intermission
3:45 59. Targeted therapy using astatinated radiopharmaceuticals. G. Vaidyanathan, M. R. Zalutsky
4:05 60. Effect of trace metal contaminants on labeling antibodies with scandium-47. K. F. Kolsky, V. Joshi, G. E. Meinken, B. Khandelwal, L. F. Mausner, M. P. Sweet, S. C. Srivastava
4:25 61. Evaluation of new somatostatin analogs with imaging and therapeutic isotopes. A. Srinivasan, M. A. Schmidt, C. J. Anderson, J. S. Lewis, J. E. Bugaj, J. L. Erion
4:45 62. Conjugation of small biomolecules and peptides with novel water-soluble dithio-bishydroxymethylbisphosphines ligands. R. Schibli, S. R. Karra, H. Gali, K. V. Katti, C. Higginbotham, C. J. Smith, T. J. Hoffman, W. A. Volkert

Section B

Nuclear Structure with Large Gamma-Ray Detector Arrays and their Auxiliary Devices

Session 2

I-Y. Lee, Presiding

1:40 63. Relativistic mean field versus Nilsson-Strutinsky description of high-spin phemonena in the "unpaired" regime. A. V. Afanasjev, I. Ragnarsson, P. Ring
2:20 64. Smooth band termination near Z=50 closed shell. D. B. Fossan
2:50 65. Magnetic rotation of nuclei: Latest results and future perspectives. R. M. Clark
3:20 Intermission
3:30 66. The decay-out of superdeformed bands in the A=190 region. T. Lauritsen, T. L. Khoo, M. P. Carpenter, G. Hackman, D. Ackermann, I. Ahmad, H. Amro, D. J. Blumenthal, S. M. Fischer, F. Hannanchi, R. V. F. Janssens, A. Korichi, A. Lopez Martins, E. F. Moore, D. T. Nisius
4:05 67. The end of superdeformation in the lead isotopes: A probe of structure at normal deformations. J. A. Cizewski, D. P. McNabb
4:35 68. Nuclear structure studies with radioactive ion beams. C. Baktash

Section C

Thirty Years of Research in Nuclear Dynamics: from Fission to the Quark-Gluon Plasma - in Memory of Kevin L. Wolf

Session 2           A. C. Mignerey, Presiding, V. E. Viola, Presiding

1:30 69. Two-particle correlations from CERN experiment NA44. J. P. Sullivan
2:05 70. Medium effects in heavy ion collisions. C. M. Ko
2:40 71. Two-pion correlation studies at the Bevalac. J. O. Rasmussen
3:15 Intermission
3:25 72. Proton source sizes versus HBT radii. M. Murray
4:00 73. Viscosity in the fission motion of hot nuclei. B. B. Back, D. J. Blumenthal, C. N. Davids, D. J. Henderson, R. Hermann, D. J. Hofman, C. L. Jiang, V. Nanal, H. T. Penttila, A. H. Wuosmaa
4:35 74. Fission time-scales, GDR and neutron clock. G. G. Chubarian

TUESDAY MORNING

Section A

Chelated Metal Ions for Diagnosis and Therapy: Symposium in Honor of Otto Gansow

Session 1           M. W. Brechbiel, Organizer, Presiding, S. B. Mirzadeh, Organizer, C. F. Meares, Presiding

8:30 Introductory Remarks
8:35 75. Bifunctional chelating agents: past, present and future. C. F. Meares
9:25 76. The IL-2/IL-15 receptor system: a target for immunotherapy of leukemia with humanized antibobies armed with beta and alpha emitting radionuclides. T. A. Waldmann, M. W. Brechbiel, K. Garmestani, C. Wu, U. Schwarz, J. A. Carrasquillo, W. C. Eckelman, O. A. Gansow
10:15 Intermission
10:30 77. Target MRI agents. M. F. Tweedle
11:20 78. Responsive lanthanide complexes. D. Parker

Section B

Nuclear Structure with Large Gamma-Ray Detector Arrays and their Auxiliary Devices

Session 3           C. Baktash, Presiding

8:30 79. Four-fold coincidence data anaylsis in radware. D. C. Radford
9:05 80. Storage and analysis of high-fold data. M. Cromaz, J. Symons, I-Y. Lee, R. W. MacLeod
9:30 81. The A=135 superdeformed region: new structures and understanding. M. A. Riley, J. Pfohl, T. B. Brown, D. J. Hartley, D. E. Archer, R. K. Sheline, M. Devlin, D. R. LaFosse, F. Lerma, D. G. Sarantites, R. M. Clark, P. Fallon, D. T. Joss, P. J. Nolan, E. S. Paul, J. Simpson, I. M. Hibbert, N. O'Brien, R. Wadsworth, Y. Sun
10:05 Intermission
10:15 82. Bifurcation and feeding of superdeformed bands. S. Flibotte
10:45 83. New Results in the study of superdeformed feeding properties. J. Wilson
11:15 84. Nuclear structure and reaction studies with the Gammasphere plus the fragment detector "CHICO". C-Y. Wu
11:50 85. Neutron-rich nuclei produced in deep inelastic reactions. I-Y. Lee

TUESDAY AFTERNOON

Section A

Chelated Metal Ions for Diagnosis and Therapy: Symposium in Honor of Otto Gansow

Session 2           C. F. Meares, Presiding, M. W. Brechbiel, Presiding

1:45 86. New metal complexes of indium, gallium, and copper for medical applications. M. J. Welch, C. J. Anderson, C. S. Cutler, J. S. Lewis, S. A. Koch, R. J. Motekaitis, A. E. Martell
2:35 87. Clinical application of targeted alpha particles for cancer therapy. D. A. Scheinberg, J. Juric, R. D. Finn, S. Larson, M. R. McDevitt, M. Geerlings, M. W. Brechbiel, O. A. Gansow
3:25 Intermission
3:40 88. Factors influencing the design of dendrimer-based MRI contrast agents. E. C. Wiener, M. W. Brechbiel, P. C. Lauterbur
4:30 89. CHX-DTPA-antibody conjugates for vascular targeted radioimmunotherapy with 213Bi and 90Y. S. J. Kennel, R. A. Boll, S. B. Mirzadeh, M. W. Brechbiel

Section B

Nuclear Structure with Large Gamma-Ray Detector Arrays and their Auxiliary Devices

Session 4           D. B. Fossan, Presiding

1:30 90. Structure of Nuclei in the f-p-g shell. S. L. Tabor
2:05 91. Studies of mass 80 sd nuclei with the microball. D. R. LaFosse
2:40 92. Comparative halflives of sd states in A=80-83 strontium isotopes. F. Lerma, D. R. LaFosse, D. G. Sarantities, R. M. Clark, I-Y. Lee, A. O. Macchiavelli, S. L. Tabor, D. Soltysik
3:00 Intermission
3:10 93. Coexistence of proton rich A~90 and A~170 nuclei. B. Cederwall, T. Back, J. Cederkall, A. Johnson, D. R. LaFosse, M. Devlin, J. Elson, F. Lerma, D. G. Sarantities, R. M. Clark, I-Y. Lee, A. O. Macchiavelli, R. W. MacLeod, R. Bark, S. Tormanen, S. Odegard, S. L. King, J. Simpson, R. D. Page, N. Amzal, D. M. Cullen, P. T. Greenless, A. Keenan, R. Lemmon, J. F. C. Cocks, K. Helariutta, P. M. Jones, R. Julin, S. Juutinen, H. Hettun
3:45 94. Superdeformation and smooth band termination in 62-Zn. C. E. Svensson, C. GS90 and GS112
4:20 95. Nuclear structure near 56Ni: Proton decay if the deformed 2nd minimum in 58Cu. D. Rudolph, C. GS54
4:55 96. A (super?) deformed high spin band in 68Zn. M. Devlin, D. R. LaFosse, F. Lerma, D. G. Sarantities, D. Rudolph, P. G. Thirolf, R. M. Clark, I-Y. Lee, A. O. Macchiavelli, R. W. MacLeod

WEDNESDAY MORNING

Section A

Chelated Metal Ions for Diagnosis and Therapy: Sympoium in honor of Otto Gansow

Session 3           S. B. Mirzadeh, Presiding, M. W. Brechbiel, Presiding

8:45   97. Strategies for in-situ production of alpha emitters. R. W. Atcher
9:05   98. Bismuth-213 conjugated to MAB for alpha-immunotherapy. L. Koch, C. Apostolidis, R. Molinet, G. Nicolaou, W. Janssens, J. van Geel
9:25   99. Samarium-153 and lutetium-177 chelation properties of selected macrocyclic and acyclic ligands. J. B. Stimmel, F. Kull
9:45   100. Copper(II) diiminedioxime complexes for imaging multidrug resistance. A. B. Packard, E. Barbarics, J. Kronauge, A. G. Jones, S. T. Treves
10:05   101. Structure-activity relationships of Schiff-base and amine phenol gallium (III) complexes and their effect on ÄMDR1Å P-glycoprotein recognition. V. Sharma, V. Polyakov, C. L. Crankshaw, D. Piwnica-Worms
10:25   Intermission
10:40   102. Starburst dendrimer-dota-metal complexes: Potential MRI contrast agents. L. H. Bryant, M. W. Brechbiel, C. Wu, J. W. M. Bulte, V. Herynek, J. A. Frank
11:00   103. Rhenium-binding hydroxamate bifunction chelating agents (BCAs): Synthesis of a trisuccin ester, CC49 antibody conjugation and 188Re labeling. A. Safavy, M. B. Khazaeli, M. S. Mayo, D. J. Buchsbaum
11:20   104. Tin-free 188Re(V)-DMSA - a potential antitumor radiopharmaceutical synthesis and biodistribution. E. Dadachova
11:40   105. Homium-166@C82: Exploring the use of metallofullerenes in nuclear medicine. L. J. Wilson, D. W. Cagle, J. M. Alford, S. J. Kennel, S. B. Mirzadeh, T. P. Thrash
12:00   106. Chelated metal ions for therapeutic and diagnostic applications. M. W. Brechbiel, O. A. Gansow, C. Wu, K. Garmestani, A. Yordanov, K. Deal, L. Chappell

Section B

Radiochemistry - Basic and Applied: Contribution of A. P. Wolf - A Celebration of his 75th Birthday

Session 1           J. S. Fowler, Organizer, M. J. Welch, Organizer, P. Shevlin, Organizer, Presiding

9:00   Introductory Remarks
9:05   107. Alfred Wolf's career at Brookhaven National Laboratory: from hot atom chemistry to imaging the human brain. J. S. Fowler
9:25   108. The fenchol-a-fenchene rearrangement. W. V. E. Doering, A. P. Wolf
9:55   109. Tracer chemistry in the laboratory and in the atmosphere. F. S. Rowland
10:25   110. Kinetic acidities by base-catalyzed tritium exchange. A. Streitwieser
10:55   Intermission
11:15   111. The interplay between hot atom chemistry and other approaches to mechanistic studies of carbon and silicon atoms. P. Gaspar, R. A. Ferrieri, A. P. Wolf
11:40   112. Stereo organic hot atom chemistry: form past models to present perceptions. R. A. Ferrieri
12:05   113. Mechanistic studies with carbon-13 atoms. P. Shevlin

WEDNESDAY AFTERNOON

Section A

Applications of Small Accelerators in Science and Industry

Session 1           J. D. Robertson, Organizer, Presiding

2:00 114. A 3He RFQ for PET isotope production. K. A. Krohn, J. M. Link, J. T. Bida, P. E. Young, D. J. Larson, R. J. Pasquinelli
2:30 115. Routine clinical production of 3 Curies per day [F-18]FDG. R. G. Manning, J. A. Clanton
3:00 116. Application of a 3.7 MeV Tandam Cascade Accelerator for PET radionuclide production. M. J. Welch, G. G. Gaehle
3:30 Intermission
3:45 117. Radioisotope production on a low energy, high beam current linear accelerator. D. Schlyer, M. L. Firouzbakht
4:15 118. Applications of CFD (computational fluid dynamics) in isotope production target design. J. Lenz
4:45 119. Accelerator-based neutron beams for the treatment of rheumatoid arthritis. R. E. Shefer, R. E. Klinhowstein, J. C. Yanch, E. Binello, D. P. Grierga

Section B

Radiochemistry - Basic and Applied - Contributions of A. P. Wolf - A Celebration of his 75th Birthday

Session 2           J. S. Fowler, Presiding

2:00 120. Quantification and visualization of local metabolic and functional activities in the brain in vivo. L. Sokoloff
2:25 121. Regional metabolism and function in health and disease. M. Reivich
2:50 122. What have we learned in 20 years about Alzheimer's disease using 18FDG-PET? M. J. deLeon, A. Alavi, S. H. Ferris, D. R. Christman, J. S. Fowler, A. P. Wolf
3:15 Intermission
3:35 123. FDG imaging to detect inflammation and infection, another important application. A. Alavi, D. Shnier
4:00 124. From FDG to FDAG. T. Ido
4:25 125. Mapping acetylcholinesterase in aging and Alzheimers disease using PET and N-[C-11]methylpiperidinyl propionate (PMP). D. E. Kuhl, R. A. Koeppe, S. Minoshima, S. E. Snyder, E. P. Ficaro, N. L. Foster, K. A. Frey, M. R. Kilborn

THURSDAY MORNING

Section A

Applications of Small Accelerators in Science and Industry

session 2           J. D. Robertson, Organizer, Presiding

9:00 126. A compact, low energy accelerator mass spectrometer for biomedical research. R. E. Klinkowstein, B. J. Hughey, R. E. Shefer, P. L. Skipper, J. S. Wishnok, S. R. Tannenbaum
9:30 127. A compact electron accelerator food irradiation facility. E. A. Knapp
10:00 128. What can you do with a mobile electron RaceTrack Microtron? W. P. Trower
10:30 Intermission
10:45 129. A small accelerator based system for broad-band ultra-sensitive elemental impurity measurements. F. D. McDaniel, S. A. Dater, B. N. Guo, S. N. Renfrow
11:05 130. Bioanalytical accelerator mass spectrometry. B. A. Buchholz, K. H. Dingley, M. L. Roberts, S. P. H. T Freeman, R. J. Mauthe
11:35 131. Initial results from the new accelerator mass spectrometer at the Navel Research Laboratory. K. S. Grabowski, D. L. Knies, T. M. DeTurck, D. J. Treacy, G. K. Hubler

Section B

Radiochemistry - Basic and Applied - Contributions of A. P. Wolf - A Celebration of his 75th Birthday

Session 3           M. J. Welch, Presiding

9:00 132. In vivo images of gene expression. M. E. Phelps, S. Gambhir, S. Cherry, D. McLaren, N. Satyamurthy, J. Barrio, H. Herschman
9:25 133. Current status of PET radiopharmaceutical developments at University of Pennsylvania: from metabolism to gene therapy. C-Y. Shiue
9:55 134. PET Studies of neurotransmitter interactions. S. L. Dewey, J. D. Brodie, A. P. Wolf
10:20 Intermission
10:40 135. Monitoring the manipulation of the dopaminergic system through the measurement of the effective turnover with fluorodopa. T. J. Ruth, D. J. Doudet, A. J. Stoessl, J. E. Holden
11:05 136. Probing the biochemical basis of the PET image. Y-S. Ding, J. S. Fowler, A. P. Wolf
11:30 137. Imaging the biochemical effects of drugs in the human brain. N. D. Volkow

THURSDAY AFTERNOON

Section A

Applications of Small Accelerators in Science and Industry

Session 3           J. D. Robertson, Organizer, Presiding

1:30 138. A review of the direct determination of light elements by high-energy resonant backscattering. J. R. Tesmer, C. J. Maggiore
2:00 139. A large lichen set collected in the western USA and analyzed by PIXE. N. F. Mangelson, B. M. Clark, L. B. Rees, L. L. St. Clair, B. B. Schaalje
2:30 140. Use of micro-PIXE in the analysis of zinc, copper, and iron in Alzheimer's disease senile plaques. M. A. Lovell, J. D. Robertson, W. J. Teesdale, J. L. Campbell, W. R. Markesbery
3:00 Intermission
3:15 141. Development of a PIXE facility at Hope College. G. Peaslee, R. J. Timmer, D. J. Barnett, A. L. VanWyngarden, M. J. Feenstra
3:45 142. A coupled gas-jet to ECR ion-source system for production of radioactive beams. D. M. Moltz, J. Cerny, R. Joosten, R. M. Larimer, C. Lyneis, E. B. Norman, J. O'Neil, J. Powell, H. Van Brocklin, Z. Q. Xie, P. E. Haustein
4:15 143. Light elements analysis by particle induced gamma ray emission (PIGE). S. D. Young, J. D. Robertson
4:45 144. PIXE analysis of western Michigan aerosol particles. A. L. VanWyngarden, G. Peaslee, R. J. Timmer, D. J. Barnett, M. J. Feenstra

Section B

Radiochemistry - Basic and Applied - Contributions of A. P. Wolf - A Celebration of his 75th Birthday

Session 4           M. J. Welch, Presiding

2:00 145. Short-lived targeted therapeutic radiopharmaceutical: the Manhattan connection revised. R. D. Finn, M. R. McDevitt, D. A. Scheinberg, J. Jurcic, S. Larson, M. W. Brechbiel, M. Geerlings, C. Apostolidis, R. Molinet, L. Bray, R. Schenter
2:25 146. DMSO protects higher order chromatin but not naked DNA from 125I decay. S. J. Adelstein, A. I. Kassis
2:50 Intermission
3:10 147. From basic organic(radio)chemistry to radiopharmaceuticals and nuclear fusion technology. H. J. Ache
3:35 148. Development of cyclotron targetry for PET. D. Schyler, M. L. Firouzbakht, R. A. Ferrieri, A. P. Wolf
4:00 149. Relationship of hot atom chemistry to PET radionuclide production. M. J. Welch